Latest Healthcare Research Reports

Tag: women’s health market drivers

  • Women’s Health Market Growth Outlook Reveals A CAGR Of 6.1% And A Market Value Of $60.99 Billion By 2030

    Women’s Health Market Growth Outlook Reveals A CAGR Of 6.1% And A Market Value Of $60.99 Billion By 2030

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    Women’s Health Market Revenue Outlook: What CAGR Is Expected Through 2030?

    The women’s health market has experienced robust expansion lately, projecting a leap from $45.36 billion in 2025 to $48.19 billion in 2026, fueled by a compound annual growth rate (CAGR) of 6.2%. This upward trajectory historically stems from a confluence of factors including a greater incidence of chronic ailments affecting women, the broadening of reproductive and hormonal healthcare offerings, heightened public understanding of diseases unique to women, intensified pharmaceutical research endeavors, and enhanced accessibility to medical infrastructure.

    Anticipating a robust expansion, the women’s health sector is projected to reach a market valuation of $60.99 billion by 2030, registering a compound annual growth rate of 6.1% over the ensuing years. This upward trajectory is fueled by a confluence of factors, including augmented investments poured into the development of drugs specifically designed for women, a heightened demand for tailored treatment methodologies, the wider implementation of early detection initiatives for various health conditions, an increasing embrace of digital health solutions, and a more pronounced emphasis on the holistic and long-term management of women’s well-being. Key developments shaping the industry landscape during this period involve the burgeoning creation of therapies precisely targeting women’s physiological needs, a greater utilization of precision medicine strategies, the integration of sophisticated diagnostic instruments, a proliferation of treatment alternatives that do not involve hormonal interventions, and an intensified commitment to proactive healthcare for women.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Women’s Health Market Growth Factors: Which Forces Are Supporting Market Expansion?

    The increasing incidence of diseases predominantly affecting women is anticipated to fuel the expansion of the women’s health market. Conditions such as anemia, osteoporosis, breast cancer, and menopausal issues are becoming more common due to factors like genetic predisposition, aging, experiencing periods before age 11 or menopause after 55, and being overweight. This surge in women’s health concerns naturally boosts the demand for products and services aimed at managing and treating these ailments, ultimately supporting overall female well-being. For example, an article released in January 2023 by the American Cancer Society, a prominent US nonprofit focused on cancer eradication, highlighted that cervical cancer was historically a leading cause of cancer-related mortality among American women. Projections for 2023 indicate that approximately 13,960 new invasive cervical cancer diagnoses will occur in the U.S., with an estimated 4,310 fatalities from the disease. Consequently, the escalating rates of women-specific illnesses are acting as a significant catalyst for the growth observed in the women’s health market.

    Women’s Health Market Segmentation: How Is The Market Structured Across Key Categories?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    Women’s Health Market Industry Trends: What Changes Are Reshaping Demand?

    Leading entities within the women’s health sector are actively deploying innovative solutions, including transcutaneous electrical nerve stimulation (TENS) technology, as a strategic move to solidify their market standing. This TENS technology represents a non-invasive intervention method, utilizing a compact, portable apparatus that administers low-voltage electrical impulses to targeted bodily regions via skin-adhered electrode patches. A notable example occurred in September 2023 when Myoovi, a company based in the United Kingdom specializing in menstrual discomfort relief, unveiled a novel TENS technology designed to alleviate the severity of menstrual cramps. Essentially, TENS generates electronic transmissions that intercept and impede the transmission of pain signals destined for the brain, thereby mitigating discomfort by disrupting these pathways. This advancement offers women a pharmaceutical-free option for confronting debilitating menstrual pain.

    Women’s Health Market Competitive Landscape And Leading Companies

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Access The Complete Women’s Health Market Report:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Women’s Health Market Largest Region: Which Geography Holds The Highest Market Share?

    North Americawas the largest region in the women’s health market in 2025. Asia-Pacificis expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers

    Women’s Health Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Market Value Trend Is Expected For The Women’s Health Market From 2026 To 2030?

    The women’s health market has experienced significant growth in recent years. It is expected to expand from $45.36 billion in 2025 to $48.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to the increasing prevalence of chronic conditions among women, the expansion of gynecological healthcare services, rising awareness of women-specific diseases, an increase in pharmaceutical research activities, and improved access to healthcare facilities.

    The women’s health market size is projected for substantial expansion in the coming years. Its valuation is anticipated to reach $60.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This expansion during the forecast period stems from greater investments in drug development tailored for women, a heightened need for customized treatment strategies, wider availability of early screening initiatives, increasing integration of digital health solutions, and a stronger emphasis on managing women’s health over the long term. Key developments expected during this period involve more targeted therapies for women, a greater embrace of precision medicine approaches, increased deployment of advanced diagnostic tools, broader availability of non-hormonal treatment alternatives, and an intensified focus on proactive women’s healthcare.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    What Key Growth Drivers Are Influencing The Women’s Health Market?

    The increasing occurrence of diseases primarily affecting women is anticipated to boost the expansion of the women’s health market going forward. Conditions specific to women, including anemia, osteoporosis, breast cancer, and menopause, are widespread, often linked to various risk factors such as family history, advanced age, early menstruation or late menopause after 55 years, and obesity. This growing prevalence directly fuels the demand for products and services in women’s health, essential for managing these conditions and supporting women’s overall well-being. As an illustration, the American Cancer Society, a US-based non-profit focused on cancer eradication, reported in an article from January 2023 that cervical cancer historically ranked among the leading causes of cancer mortality for American women. It also projected approximately 13,960 new diagnoses of invasive cervical cancer in the USA during 2023, with an estimated 4,310 women succumbing to the disease. Consequently, the increasing incidence of women-specific diseases is propelling the growth of the women’s health market.

    What Are The Core Segment Classifications In The Women’s Health Market?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    Which Trends Are Affecting The Women’s Health Market Framework?

    Leading enterprises within the women’s digital health market are prioritizing the delivery of cutting-edge technological solutions, including the digital health passport initiative, to improve access to customized healthcare services. This digital health passport concept denotes an online platform built to enable individuals to securely and efficiently oversee and disseminate their personal health data. A notable example occurred in July 2024 when Algorand, a foundation located in Singapore, partnered with the Self-Employed Women’s Association (SEWA) to introduce a Digital Health Passport initiative, aiming to bolster healthcare access for women in the informal economy. As a component of Algorand’s AlgoBharat program in India, this venture employs blockchain technology to establish secure, unalterable records of women’s health qualifications. Access to these digital health passports for women is facilitated via SEWA Shakti Kendras, which are designed to offer assistance in maneuvering health services and signing up for initiatives such as Ayushman Bharat.

    Which Companies Are Influencing The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Access The Complete Women’s Health Market Report:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Holds The Largest Share In The Women’s Health Market?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Women’s Health Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Menstrual Health Apps Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/menstrual-health-apps-global-market-report

    Womens Health Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Market Forecast with Demand and Growth Insights

    Women’s Health Market Forecast with Demand and Growth Insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Women’s Health Market Expected To Change From 2026 To 2030?

    The market size for women’s health has experienced significant expansion in recent times. Projections indicate it will increase from $45.36 billion in 2025 to $48.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion can be linked to several factors, including a rise in chronic conditions affecting women, the broadening of gynecological healthcare services, increased understanding of diseases unique to women, advancements in pharmaceutical research, and enhanced access to healthcare provisions.

    The women’s health market is projected to experience significant growth over the next few years, with its size expected to reach $60.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This expansion during the forecast period is driven by increasing investments in drug development focused on women, a rising demand for personalized treatment plans, the expansion of early screening programs, a growing adoption of digital health integration, and an increasing emphasis on long-term women’s health management. Prominent trends for this period include the growing development of targeted therapies for women, the rising adoption of precision medicine approaches, an expanded use of advanced diagnostic tools, the broadening of non-hormonal treatment options, and an enhanced focus on preventive women’s healthcare.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    What Key Factors Are Affecting The Women’s Health Market Demand?

    The growing occurrence of conditions primarily affecting women is anticipated to boost the expansion of the women’s health market in the future. Diseases predominantly impacting women, including anemia, osteoporosis, breast cancer, and menopause, among others, are frequently observed due to a range of risk factors such as family history, advanced age, menstruation beginning early or menopause occurring past 55 years, and obesity, among others. This increasing incidence of women-specific ailments fuels the need for women’s health products and services essential for their treatment and for upholding women’s overall health and well-being. For example, the American Cancer Society, a US-based non-profit organization focused on eradicating cancer, released an article in January 2023, stating that cervical cancer used to be a leading cause of cancer-related mortality among American women. Approximately 13,960 new cases of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with an estimated 4,310 women expected to succumb to the disease. Consequently, the increasing occurrence of diseases specific to women is fostering the expansion of the women’s health market.

    How Are Different Segments Classified In The Women’s Health Market Segment Analysis?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    What Trends Are Influencing Changes In The Women’s Health Market?

    Leading companies operating within the women’s health market are introducing new technologies to sustain their position, including transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic method that involves using a small, battery-operated device to deliver low-voltage electrical currents to specific areas of the body through electrode pads placed on the skin. For instance, in September 2023, Myoovi, a UK-based menstrual pain solutions provider, launched a new transcutaneous electrical nerve stimulation (TENS) technology designed to manage painful menstruation cramps. TENS operates by producing electrical signals that interfere with and block the pain signals attempting to reach the brain. This instrument facilitates reduced pain by disrupting and blocking these pain signals. This innovative technology offers women a drug-free alternative for tackling painful menstrual cramps.

    Who Are The Companies Driving Activity In The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Get The Full Women’s Health Market Report:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Leads The Women’s Health Market In Terms Of Market Share?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Women’s Health Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Menstrual Health Apps Market Report 2026

    https://www.thebusinessresearchcompany.com/report/menstrual-health-apps-global-market-report

    Womens Health Devices Market Report

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health Market Report

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Women’s Health Industry Trends and Market Growth Forecast for 2026–2030

    Global Women’s Health Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Increase Is Anticipated For The Women’s Health Market Over The 2026–2030 Period?

    The women’s health market has experienced robust expansion in recent times. Projections indicate it will expand from $45.36 billion in 2025 to $48.19 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this growth was driven by factors such as a greater occurrence of chronic illnesses in women, the broadening of gynecological healthcare provisions, heightened understanding of diseases particular to women, an increase in pharmaceutical research, and enhanced availability of healthcare services.

    The women’s health market is projected to experience robust expansion in the coming years. This market is anticipated to reach $60.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Key factors driving this growth over the forecast period include greater investments in drug development specifically for women, a surge in demand for tailored treatment solutions, the broadening of early screening initiatives, increasing integration of digital health technologies, and an enhanced emphasis on comprehensive long-term women’s health management. Significant trends expected during this period involve the increasing creation of targeted therapies for women, a rising embrace of precision medicine strategies, expanded utilization of advanced diagnostic instruments, the broadening of non-hormonal treatment alternatives, and a heightened focus on proactive women’s healthcare.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    What Underlying Factors Are Accelerating The Growth Of The Women’s Health Market?

    The increasing occurrence of women-focused ailments is projected to stimulate the expansion of the women’s health market in the future. Conditions predominantly affecting women, including anemia, osteoporosis, breast cancer, and menopause, are widespread, stemming from diverse risk factors like genetic predisposition, advancing age, premature menstruation or delayed menopause beyond 55 years, and excess weight. This growing incidence of women-specific illnesses fuels the need for healthcare products and services essential for their treatment and for safeguarding women’s overall well-being. As an illustration, the American Cancer Society, a US-based non-profit organization focused on eradicating cancer, released an article in January 2023 stating that cervical cancer previously ranked among the primary causes of cancer fatalities for American women. Approximately 13,960 new instances of invasive cervical cancer are anticipated to be diagnosed in the USA in 2023, with an estimated 4,310 women expected to succumb to the disease. Consequently, the increasing prevalence of women-centric diseases is accelerating the expansion of the women’s health market.

    How Is The Women’s Health Market Segmented Across Key Categories?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    Which Trends Are Influencing The Women’s Health Market?

    Leading companies in the women’s health market are introducing new technologies to sustain their position, including the transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic method that involves using a small, battery-operated device to deliver low-voltage electrical currents to specific body areas through electrode pads placed on the skin. For instance, in September 2023, Myoovi, a UK-based provider of menstrual pain solutions, launched its new transcutaneous electrical nerve stimulation (TENS) technology to manage painful menstruation cramps. TENS generates electrical signals that interfere with and block pain signals attempting to reach the brain. This instrument enables less pain by disrupting and obstructing these pain signals. This new technology offers women a drug-free alternative for tackling painful menstrual cramps.

    Who Are The Dominant Players Shaping The Women’s Health Market Landscape?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Read the full women’s health market report here:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Is Projected To Dominate The Women’s Health Market During The Forecast Period?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Women’s Health Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Menstrual Health Apps Global Market Report

    https://www.thebusinessresearchcompany.com/report/menstrual-health-apps-global-market-report

    Womens Health Devices Global Market Report

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health Global Market Report

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the women’s health market from 2026–2035 with trusted insights from The Business Research Company

    By how much is the Women’s Health Market expected to grow between 2026 and 2030?

    The women’s health market size has shown significant expansion in recent years. It is predicted to expand from $45.36 billion in 2025 to $48.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The historical growth can be linked to the increasing occurrence of chronic conditions affecting women, the development of gynecological healthcare services, growing understanding of diseases specific to women, an increase in pharmaceutical research efforts, and improved access to medical facilities.

    The women’s health market is projected to experience substantial expansion in the coming years. By 2030, its size is forecast to reach $60.99 billion, expanding at a compound annual growth rate (CAGR) of 6.1%. This anticipated growth stems from several factors, including heightened investments in pharmaceutical development specifically for women, an escalating demand for customized treatment approaches, the broadening of early detection initiatives, increased incorporation of digital health technologies, and a greater emphasis on sustained women’s health care. Prominent trends for the upcoming period encompass the expanding creation of targeted therapies for women, the increasing embrace of precision medicine techniques, wider application of sophisticated diagnostic instruments, the availability of more non-hormonal treatment alternatives, and a reinforced commitment to preventive women’s healthcare.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Which Drivers Are Influencing Market Acceleration In The Women’s Health Market?

    The increasing incidence of women-focused ailments is projected to boost the expansion of the women’s health market in the future. Conditions predominantly affecting women, including anemia, osteoporosis, breast cancer, and menopause, among others, are frequently observed, attributed to diverse risk factors such as genetic predisposition, advancing age, premature menstruation or late-onset menopause (after 55 years), and obesity. This growing occurrence of female-specific illnesses fuels the need for women’s health products and services essential for their treatment and for maintaining overall female health and well-being. For example, the American Cancer Society, a US-based non-profit dedicated to cancer eradication, released an article in January 2023, stating that cervical cancer was formerly among the leading causes of cancer fatalities for women in America. Approximately 13,960 new instances of invasive cervical cancer are anticipated to be diagnosed in the USA during 2023, with an estimated 4,310 women predicted to succumb to the disease. Consequently, the increasing incidence of women-centric diseases is a primary driver for the growth of the women’s health market.

    What Segments Are Identified Within The Structure Of The Women’s Health Market?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    What Trends Are Reshaping The Dynamics Of The Women’s Health Market?

    Leading companies in the women’s health market are integrating novel technologies to maintain their standing, exemplified by transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic method employing a small, battery-operated device that delivers low-voltage electrical currents to specific body areas via electrode pads placed on the skin. As an illustration, in September 2023, Myoovi, a UK-based company specializing in menstrual pain solutions, unveiled its TENS technology designed to alleviate painful menstrual cramps. TENS works by producing electrical signals that interrupt and impede pain signals from reaching the brain. This instrument effectively lessens pain by disturbing and blocking these pain signals, offering women a drug-free option to manage severe menstrual discomfort.

    Which Key Players Are Driving Competition In The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Is Projected To Lead The Women’s Health Market During The Forecast Period?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Women’s Health Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Womens Health Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

    Womens Health Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health App Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-app-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the women’s health market from 2026–2035 with trusted insights from The Business Research Company

    By how much is the Women’s Health Market expected to grow between 2026 and 2030?

    The women’s health market size has shown significant expansion in recent years. It is predicted to expand from $45.36 billion in 2025 to $48.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The historical growth can be linked to the increasing occurrence of chronic conditions affecting women, the development of gynecological healthcare services, growing understanding of diseases specific to women, an increase in pharmaceutical research efforts, and improved access to medical facilities.

    The women’s health market is projected to experience substantial expansion in the coming years. By 2030, its size is forecast to reach $60.99 billion, expanding at a compound annual growth rate (CAGR) of 6.1%. This anticipated growth stems from several factors, including heightened investments in pharmaceutical development specifically for women, an escalating demand for customized treatment approaches, the broadening of early detection initiatives, increased incorporation of digital health technologies, and a greater emphasis on sustained women’s health care. Prominent trends for the upcoming period encompass the expanding creation of targeted therapies for women, the increasing embrace of precision medicine techniques, wider application of sophisticated diagnostic instruments, the availability of more non-hormonal treatment alternatives, and a reinforced commitment to preventive women’s healthcare.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Which Drivers Are Influencing Market Acceleration In The Women’s Health Market?

    The increasing incidence of women-focused ailments is projected to boost the expansion of the women’s health market in the future. Conditions predominantly affecting women, including anemia, osteoporosis, breast cancer, and menopause, among others, are frequently observed, attributed to diverse risk factors such as genetic predisposition, advancing age, premature menstruation or late-onset menopause (after 55 years), and obesity. This growing occurrence of female-specific illnesses fuels the need for women’s health products and services essential for their treatment and for maintaining overall female health and well-being. For example, the American Cancer Society, a US-based non-profit dedicated to cancer eradication, released an article in January 2023, stating that cervical cancer was formerly among the leading causes of cancer fatalities for women in America. Approximately 13,960 new instances of invasive cervical cancer are anticipated to be diagnosed in the USA during 2023, with an estimated 4,310 women predicted to succumb to the disease. Consequently, the increasing incidence of women-centric diseases is a primary driver for the growth of the women’s health market.

    What Segments Are Identified Within The Structure Of The Women’s Health Market?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    What Trends Are Reshaping The Dynamics Of The Women’s Health Market?

    Leading companies in the women’s health market are integrating novel technologies to maintain their standing, exemplified by transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic method employing a small, battery-operated device that delivers low-voltage electrical currents to specific body areas via electrode pads placed on the skin. As an illustration, in September 2023, Myoovi, a UK-based company specializing in menstrual pain solutions, unveiled its TENS technology designed to alleviate painful menstrual cramps. TENS works by producing electrical signals that interrupt and impede pain signals from reaching the brain. This instrument effectively lessens pain by disturbing and blocking these pain signals, offering women a drug-free option to manage severe menstrual discomfort.

    Which Key Players Are Driving Competition In The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Is Projected To Lead The Women’s Health Market During The Forecast Period?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Women’s Health Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Womens Health Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

    Womens Health Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health App Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-app-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Women’s Health Global Forecast: Market to Scale Up to $60.99 Billion by 2030 at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the women’s health market from 2026–2035 with trusted insights from The Business Research Company

    By how much is the Women’s Health Market expected to grow between 2026 and 2030?

    The women’s health market size has shown significant expansion in recent years. It is predicted to expand from $45.36 billion in 2025 to $48.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The historical growth can be linked to the increasing occurrence of chronic conditions affecting women, the development of gynecological healthcare services, growing understanding of diseases specific to women, an increase in pharmaceutical research efforts, and improved access to medical facilities.

    The women’s health market is projected to experience substantial expansion in the coming years. By 2030, its size is forecast to reach $60.99 billion, expanding at a compound annual growth rate (CAGR) of 6.1%. This anticipated growth stems from several factors, including heightened investments in pharmaceutical development specifically for women, an escalating demand for customized treatment approaches, the broadening of early detection initiatives, increased incorporation of digital health technologies, and a greater emphasis on sustained women’s health care. Prominent trends for the upcoming period encompass the expanding creation of targeted therapies for women, the increasing embrace of precision medicine techniques, wider application of sophisticated diagnostic instruments, the availability of more non-hormonal treatment alternatives, and a reinforced commitment to preventive women’s healthcare.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Which Drivers Are Influencing Market Acceleration In The Women’s Health Market?

    The increasing incidence of women-focused ailments is projected to boost the expansion of the women’s health market in the future. Conditions predominantly affecting women, including anemia, osteoporosis, breast cancer, and menopause, among others, are frequently observed, attributed to diverse risk factors such as genetic predisposition, advancing age, premature menstruation or late-onset menopause (after 55 years), and obesity. This growing occurrence of female-specific illnesses fuels the need for women’s health products and services essential for their treatment and for maintaining overall female health and well-being. For example, the American Cancer Society, a US-based non-profit dedicated to cancer eradication, released an article in January 2023, stating that cervical cancer was formerly among the leading causes of cancer fatalities for women in America. Approximately 13,960 new instances of invasive cervical cancer are anticipated to be diagnosed in the USA during 2023, with an estimated 4,310 women predicted to succumb to the disease. Consequently, the increasing incidence of women-centric diseases is a primary driver for the growth of the women’s health market.

    What Segments Are Identified Within The Structure Of The Women’s Health Market?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    What Trends Are Reshaping The Dynamics Of The Women’s Health Market?

    Leading companies in the women’s health market are integrating novel technologies to maintain their standing, exemplified by transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic method employing a small, battery-operated device that delivers low-voltage electrical currents to specific body areas via electrode pads placed on the skin. As an illustration, in September 2023, Myoovi, a UK-based company specializing in menstrual pain solutions, unveiled its TENS technology designed to alleviate painful menstrual cramps. TENS works by producing electrical signals that interrupt and impede pain signals from reaching the brain. This instrument effectively lessens pain by disturbing and blocking these pain signals, offering women a drug-free option to manage severe menstrual discomfort.

    Which Key Players Are Driving Competition In The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Is Projected To Lead The Women’s Health Market During The Forecast Period?

    North America was the largest region in the women’s health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Women’s Health Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2026, By The Business Research Company

    Womens Health Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

    Womens Health Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

    Womens Health App Market Report 2026

    https://www.thebusinessresearchcompany.com/report/womens-health-app-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Market Growth Opportunities: Insights from 2025–2029

    Women’s Health Market Growth Opportunities: Insights from 2025–2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    By How Much Is The Women’s Health Market Expected To Expand Between 2025 And 2029?

    The women’s health market has experienced consistent expansion in its size over recent years. Projections indicate a rise from $43.53 billion in 2024 to $45.36 billion by 2025, reflecting a compound annual growth rate (CAGR) of 4.2%. This past growth is largely attributable to progress in reproductive medicine, enhanced awareness and education programs, significant empowerment and advocacy efforts, improvements in prenatal and postnatal care, and the ongoing development of hormone replacement therapies.

    The women’s health market size is anticipated to expand significantly in the coming years, reaching $57.59 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. This growth over the forecast period is driven by factors such as precision medicine in gynecology, an increase in female-focused clinical trials, the expanded use of non-invasive prenatal testing, broader access to fertility treatments, and a growing focus on mental health. Key trends during this period are expected to include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women’s health diagnostics, and the integration of artificial intelligence (AI).

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Which Drivers Are Impacting The Women’s Health Market?

    The increasing occurrence of conditions predominantly affecting women is anticipated to fuel the expansion of the women’s health market in the future. Disorders specific to women, including anemia, osteoporosis, breast cancer, and menopause, are frequently observed, linked to diverse risk factors such as genetic predisposition, advancing age, premature menstruation or menopause after 55 years, and obesity. This increase in women-centric diseases consequently boosts the need for women’s health products and services essential for managing these conditions and maintaining female well-being. For example, the American Cancer Society, a US-based non-profit organization focused on cancer eradication, reported in an January 2023 article that cervical cancer was historically a leading cause of cancer mortality among American women. Approximately 13,960 new instances of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with an estimated 4,310 women expected to succumb to the disease. Consequently, the growing prevalence of women-centric diseases is a key factor propelling the development of the women’s health market.

    What Are The Major Segment Categories Driving The Women’s Health Market Growth?

    The women’s healthmarket covered in this report is segmented –

    1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline

    2) By Age: 50 Years & above ; Other Ages

    3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries

    4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps

    2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments

    What Are The Major Trends Driving The Growth Of The Women’s Health Market?

    Significant advancements within women’s health represent a pivotal trend in the women’s health market. Leading firms active in the women’s health market are innovating new offerings to solidify their competitive standing. An example of this is GE Healthcare, a US-based medical technology company, introducing the Voluson Expert 22 in July 2022. This newest product in their women’s health range utilizes graphic-based beam former technology, providing excellent image clarity and increased adaptability in imaging capabilities. The system, incorporating advanced Artificial Intelligence (AI) tools, guarantees higher uniformity in examinations and minimizes necessary operational tasks.

    Who Are The Major Companies Operating In The Women’s Health Market?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    Which Region Is Expected To Witness The Fastest Growth In The Women’s Health Market?

    North America was the largest region in the women’s health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Women’s Health Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Browse Through More Reports Similar to the Global Women’s Health Market 2025, By The Business Research Company

    Feminine Hygiene Products Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/feminine-hygiene-products-global-market-report

    Feminine Wipes Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/feminine-wipes-global-market-report

    Polycystic Ovarian Syndrome Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Market Forecast Reaching $57.59 Billion by 2029 at 6.2% CAGR

    Women’s Health Market Forecast Reaching $57.59 Billion by 2029 at 6.2% CAGR

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Anticipated CAGR of the Women’s Health Market, and What Factors Will Drive It?

    The market size for women’s health has witnessed constant growth in the past few years. It is projected to expand from $43.53 billion in 2024 to $45.36 billion in 2025, marking a compound annual growth rate (CAGR) of 4.2%. The past growth trend can be credited to factors such as improvements in reproductive medicine, various awareness and education programs, empowerment and advocacy efforts, advancements in prenatal and postnatal care, and the introduction of hormone replacement therapies.

    The market for women’s health is predicted to experience significant expansion in the upcoming years, reaching a projected worth of $57.59 billion in 2029, growing at a compounded annual growth rate (CAGR) of 6.2%. The anticipated growth during this period is largely due to advancements in precision medicine within the field of gynecology, an increase in clinical trials centred on women, broader utilization of non-invasive prenatal tests, enhanced access to fertility procedures, and a heightened emphasis on mental health. Key trends for this forecasted period encompass digital health technologies, tracking of fertility and reproductive health, alternatives for non-hormonal contraceptives, monitoring of maternal health and pregnancy, developments in diagnostic procedures for women’s health, along with the incorporation of artificial intelligence (AI).

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Women’s Health Market?

    The growing incidence of female-specific illnesses is projected to hasten the expansion of the women’s health sector. Women-specific illnesses like anemia, osteoporosis, breast cancer, menopause, and others, are increasingly prevalent due to a myriad of risk factors such as family background, advancing age, premature commencement of menstruation or menopause after the age of 55, obesity, amongst others. This growing rate of female-specific illnesses boosts the need for products and services centered on women’s health, which are necessary to address these diseases and assure women’s overall health and wellness. For example, in January 2023, the American Cancer Society, a US non-profit organization intent on eradicating cancer, released an article stating that cervical cancer was once one of the leading causes of cancer deaths among American women. They anticipate about 13,960 new cases of invasive cervical cancer will emerge in the U.S in 2023, and roughly 4,310 women are likely to succumb to cervical cancer. Hence, the escalating incidence of female-specific illnesses fuels the development of the women’s health sector.

    Which Key Market Segments Comprise the Women’s Health Market and Drive Its Revenue Growth?

    The women’s healthmarket covered in this report is segmented –

    1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline

    2) By Age: 50 Years & above ; Other Ages

    3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries

    4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps

    2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    Which Areas Are Leading Regions in the Women’s Health Market Expansion Across the Globe?

    North America was the largest region in the women’s health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Market Trends in theWomen’s Health Market Over the Coming Years?

    Progress in the field of women’s health is a significant trend in the women’s health market. Major firms in this market are introducing innovative products to solidify their standings. For instance, in July 2022, US-based medical technology firm GE Healthcare unveiled the Voluson Expert 22, a novel addition to their women’s health product line. This new tool uses graphic-based beam former technology, providing high-quality imaging and increased adaptability in imaging capabilities. The system, equipped with advanced tools powered by Artificial Intelligence (AI), offers increased uniformity in examinations while also decreasing the needed tasks.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    How Is the Women’s Health Market Conceptually Defined?

    Women’s health refers to the branch of medicine and healthcare that focuses on the diagnosis, treatment, and prevention of diseases and conditions that specifically affect women. It encompasses a wide range of issues including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions such as breast and ovarian cancers. It also addresses other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8017

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Women’s Health Market Trends Report 2025 – For Business Development and Strategy Teams

    Women’s Health Market Trends Report 2025 – For Business Development and Strategy Teams

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Women’s Health Market Growth in 2025?

    Over the recent years, the market size for women’s health has consistently increased. The market worth, which is predicted to be $43.53 billion in 2024, is expected to rise to $45.5 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. Factors contributing to the growth during the historical period include improvements in reproductive medicine, initiatives for awareness and education, movements for empowerment and advocacy, advancements in prenatal and postnatal care, as well as the development of hormone replacement therapies.

    What Is the Forecast for the Women’s Health Market Size Through 2029?

    Anticipated robust growth in the women’s health market will likely elevate its valuation to $58.07 billion by 2029, marking an impressive compound annual growth rate (CAGR) of 6.3%. This projected increase during the forecast period is attributable to factors such as the application of precision medicine in gynecology, an uptick in clinical trials predominantly centered around women, greater utilization of non-invasive prenatal testing, improved access to fertility therapies, and a sharpened emphasis on mental health. The period is also expected to witness significant trends including the adoption of digital health solutions, advancements in fertility and reproductive health tracking, the introduction of non-hormonal contraception options, enhanced maternal health and pregnancy monitoring capabilities, progress in women’s health diagnostics, and the incorporation of artificial intelligence (AI).

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

    What are the Key Market Players in Women’s Health Market and How They’re Evolving?

    Major companies operating in the women’s health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG

    What Are the Primary Growth Drivers in the Women’s Health Market?

    The escalating occurrence of diseases primarily impacting women is anticipated to boost the growth of the women’s health market in the future. Conditions such as anemia, osteoporosis, breast cancer, menopause, among others, frequently occur due to numerous risk factors such as familial history, advancing age, early start of menstrual cycles or menopause after the age of 55, obesity, and more. Consequently, this surge in diseases primarily affecting women is fueling the demand for health products and services specifically designed to treat these conditions and maintain women’s health and wellness. For example, the American Cancer Society, a non-profit US organization committed to cancer eradication, released an article in January 2023 stating that cervical cancer used to be one of the leading causes of cancer death among American women. Approximately 13,960 new invasive cervical cancer cases are projected to be diagnosed in the USA in 2023, of which about 4,310 are anticipated to result in death. Thus, the escalating incidence of women-centric diseases is contributing to the growth of the women’s health market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

    What Are the Leading Segments in the Global Women’s Health Industry?

    The women’s health market covered in this report is segmented –

    1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

    2) By Age: 50 Years & above , Other Ages

    3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

    4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

    5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Subsegments:

    1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

    2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

    3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

    What Are the Key Market Trends in the Women’s Health Industry?

    Advancements in the field of women’s health is a significant trend in that market. Leading businesses in the industry are introducing innovative products to consolidate their standing. For example, in July 2022, GE Healthcare, a medical technology firm based in the USA, unveiled the Voluson Expert 22. This recent addition to their women’s health range uses graphics-based beam former technology to provide excellent image quality and improved adaptability in imaging tasks. The system, armed with state-of-the-art AI-driven tools, offers more consistency in evaluations and cuts down the number of necessary tasks.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

    What Is the Regional Outlook for the Women’s Health Market?

    North America was the largest region in the women’s health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8017

    This Report Delivers Insight On:

    1. How big is the women’s health market, and how is it changing globally?

    2. Who are the major companies in the women’s health market, and how are they performing?

    3. What are the key opportunities and risks in the women’s health market right now?

    4. Which products or customer segments are growing the most in the women’s health market?

    5. What factors are helping or slowing down the growth of the women’s health market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model